abstract |
A compound according to formula (I) Wherein R 1 , L A , Cy A , R A , R 2 , R 3 and R 4 are as described herein. The present invention relates to novel compounds according to formula I which antagonize GPR84, a G-protein-coupled receptor in connection with an inflammatory condition, and to processes for the preparation of said novel compounds, pharmaceutical compositions comprising said compounds, The prevention and / or treatment of diseases accompanied by impaired inflammatory conditions, pain, neuroinflammatory conditions, neurodegenerative conditions, infectious diseases, autoimmune diseases, endocrine and / or metabolic diseases, cardiovascular diseases, leukemias and / / ≪ / RTI > |